An inexpensive blood pressure drug could improve the health of cancer patients, according to a recent preclinical study. The drug, telmisartan, is FDA-approved to treat hypertension (high blood ...
Lebanon, N.H.—In a new Dartmouth Cancer Center (DCC) study led by clinical researcher Tyler J. Curiel, MD, MPH, FACP, investigators found that the FDA-approved blood pressure drug telmisartan can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results